Please assess the completion status of the following clinical trial:

Trial Title: Predicting Lung Injury From Transfusion in Patients With Liver Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria: Subjects will be eligible to participate in the study if they meet all of the following criteria:~1. Admit to an ICU due to gastrointestinal bleeding AND an INR \> 1.5~2. Patient has chronic liver disease defined as 1 or more of the three following diagnostic criteria:~   1. Previous diagnosis of chronic liver disease OR Imaging or biopsy diagnosis of cirrhosis~  2. Signs of portal hypertension (ascites, varices, hypersplenism)~  3. Laboratory evidence of synthetic dysfunction (INR\>1.5, Bilirubin\> 2.0, Albumin\< 2.5) AND ≥2 physical exam findings on admission associated with chronic liver disease (palmar erythema, spider angiomata, asterixis, caput medusa, gynecomastia)~Exclusion criteria: Subjects will be ineligible to participate in the study if they meet any of the following criteria~1. Patient under age 18 OR pregnant OR incarcerated~2. Patient meets criteria for acute respiratory distress syndrome (ARDS) (PaO2/FiO2\<165)~3. Patient admitted to ICU for re-bleed on same hospital admission OR has already received \>4 units of plasma.~4. History of inheritable or acquired clotting or bleeding disorder~5. Patient actively anticoagulated or has recently received (within 72h) vitamin K antagonists, direct thrombin inhibitors, heparins or Xa antagonists

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).